论文部分内容阅读
“新版GMP规范出台将淘汰一大批中小药企。”中投顾问医药行业研究员郭凡礼分析说,我国目前有九成左右的药企都属于中小企业,其中最好的年销售额在1亿元上下,大
“The introduction of the new GMP standard will be phased out a large number of small and medium-sized pharmaceutical companies. ” Investment consultant in the pharmaceutical industry researcher Guo Fanli said that currently about 90% of Chinese pharmaceutical companies are SMEs, of which the best annual sales of 1 billion Yuan up and down, big